公开(公告)号：US10954233B2

公开(公告)日：2021-03-23

申请号：US16330820

申请日：2017-09-06

Applicant: Novartis AG

Inventor： Phillip Alper ,  Jonathan Deane ,  Songchun Jiang ,  Tao Jiang ,  Thomas Knoepfel ,  Pierre-Yves Michellys ,  Daniel Mutnick ,  Wei Pei ,  Peter Syka ,  Guobao Zhang ,  Yi Zhang

IPC: C07D471/04 ,  A61K31/437 ,  A61K31/4375 ,  A61P17/06 ,  A61P1/16 ,  A61P37/06 ,  A61P19/02 ,  A61K31/496 ,  A61K31/519 ,  A61K31/5377 ,  A61K31/541 ,  A61K45/06

Abstract: The invention disclosed herein relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridinyl compounds of Formula (A), pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of autoimmune diseases.